
Vesper Medical Announces First Enrollment in the VIVID Trial
MALVERN, PA — Vesper Medical, Inc., a developer of medical devices for deep venous disease, announced initiation of its U.S. Food and Drug Administration (FDA) Investigational Exemption (IDE) study – …
Read More